In summary, our study demonstrated that activation of the PGF2α/PTGFR axis accelerates experimental proliferative retinopathy through the secretion of ELR+ CXC chemokines via FOS‐mediated transcriptional regulation. The gene discussed is PTGFR; the disease is retinal disorder.